Furthermore, a study involving 93 prostate cancer patients from the Italian cohort identified that high expression of CD68 in primary tumor identified by IHC was an independent predictor of biochemical recurrence (defined as elevation of PSA level) after radical prostatectomy (263). This evidence concerns the gene CD68 and prostate cancer.